Amgen (AMGN) Cash & Current Investments (2009 - 2026)
Amgen's quarterly Cash & Current Investments came in at $12.0 billion in Q1 2026, up 36.64% year-on-year from $8.8 billion in Q1 2025, and up 31.87% quarter-over-quarter from $9.1 billion in Q4 2025.
Amgen has reported Cash & Current Investments for 18 years, with the latest figure at $12.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 36.64% year-over-year to $12.0 billion; the trailing twelve-month figure through Mar 2026 stood at $12.0 billion (up 36.64% YoY), and the FY2025 full-year result was $9.1 billion, down 23.75% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $12.0 billion, up from $9.1 billion in the prior quarter.
- The five-year high for Cash & Current Investments was $34.7 billion in Q3 2023, with the low at $6.5 billion in Q1 2022.
- Average Cash & Current Investments over 5 years is $13.7 billion, with a median of $9.4 billion recorded in 2025.
- Year-over-year, Cash & Current Investments soared 382.29% in 2023 and tumbled 74.06% in 2024.
- Tracing AMGN's Cash & Current Investments over 5 years: stood at $9.3 billion in 2022, then advanced by 17.61% to $10.9 billion in 2023, then grew by 9.4% to $12.0 billion in 2024, then declined by 23.75% to $9.1 billion in 2025, then jumped by 31.87% to $12.0 billion in 2026.
- The last three Cash & Current Investments figures came in at $12.0 billion (Q1 2026), $9.1 billion (Q4 2025), and $9.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 9.39 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 5.70 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 7.64 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 13.08 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 10.49 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.04 Bn |
| Dec 31, 2025 | 9.13 Bn |
| Sep 30, 2025 | 9.45 Bn |
| Jun 30, 2025 | 8.03 Bn |
| Mar 31, 2025 | 8.81 Bn |
| Dec 31, 2024 | 11.97 Bn |
| Sep 30, 2024 | 9.01 Bn |
| Jun 30, 2024 | 9.30 Bn |
| Mar 31, 2024 | 9.71 Bn |
| Dec 31, 2023 | 10.94 Bn |
| Sep 30, 2023 | 34.74 Bn |
| Jun 30, 2023 | 34.25 Bn |
| Mar 31, 2023 | 31.56 Bn |
| Dec 31, 2022 | 9.31 Bn |
| Sep 30, 2022 | 11.48 Bn |
| Jun 30, 2022 | 7.18 Bn |
| Mar 31, 2022 | 6.54 Bn |
| Dec 31, 2021 | 8.04 Bn |
| Sep 30, 2021 | 12.92 Bn |
| Jun 30, 2021 | 8.08 Bn |
| Mar 31, 2021 | 10.57 Bn |
| Dec 31, 2020 | 10.65 Bn |
| Sep 30, 2020 | 12.36 Bn |
| Jun 30, 2020 | 11.42 Bn |
| Mar 31, 2020 | 8.01 Bn |
| Dec 31, 2019 | 8.91 Bn |
| Sep 30, 2019 | 20.85 Bn |
| Jun 30, 2019 | 21.76 Bn |
| Mar 31, 2019 | 26.30 Bn |
| Dec 31, 2018 | 29.30 Bn |
| Sep 30, 2018 | 29.92 Bn |
| Jun 30, 2018 | 29.40 Bn |
| Mar 31, 2018 | 32.17 Bn |
| Dec 31, 2017 | 41.68 Bn |
| Sep 30, 2017 | 41.35 Bn |
| Jun 30, 2017 | 39.23 Bn |
| Mar 31, 2017 | 38.40 Bn |
| Dec 31, 2016 | 38.09 Bn |
| Sep 30, 2016 | 37.98 Bn |
| Jun 30, 2016 | 35.03 Bn |
| Mar 31, 2016 | 34.74 Bn |
| Dec 31, 2015 | 31.38 Bn |
| Sep 30, 2015 | 31.12 Bn |
| Jun 30, 2015 | 29.99 Bn |
| Mar 31, 2015 | 27.12 Bn |
| Dec 31, 2014 | 27.03 Bn |
| Sep 30, 2014 | 28.08 Bn |
| Jun 30, 2014 | 26.19 Bn |
| Mar 31, 2014 | 19.80 Bn |
| Dec 31, 2013 | 19.40 Bn |
| Sep 30, 2013 | 11.16 Bn |
| Jun 30, 2013 | 22.02 Bn |
| Mar 31, 2013 | 21.27 Bn |
| Dec 31, 2012 | 24.06 Bn |
| Sep 30, 2012 | 25.37 Bn |
| Jun 30, 2012 | 5.85 Bn |
| Mar 31, 2012 | 4.21 Bn |
| Dec 31, 2011 | 20.64 Bn |
| Sep 30, 2011 | 22.37 Bn |
| Jun 30, 2011 | 13.21 Bn |
| Mar 31, 2011 | 7.20 Bn |
| Dec 31, 2010 | 17.89 Bn |
| Sep 30, 2010 | 11.62 Bn |
| Jun 30, 2010 | 7.61 Bn |
| Mar 31, 2010 | 5.43 Bn |
| Dec 31, 2009 | 15.30 Bn |
| Sep 30, 2009 | 14.47 Bn |
| Jun 30, 2009 | 10.45 Bn |
| Mar 31, 2009 | 2.78 Bn |